November is National Pancreatic Cancer Awareness Month, dedicated to raising awareness, supporting patients, and advancing research for better diagnosis and treatments. We would like to take this opportunity to express our gratitude to all of the researchers who have contributed to this field. In particular, we would like to share some of the innovative research findings in the related fields, published in Current Oncology (ISSN: 1718-7729). We hope this announcement will provide useful information for this field.
“Pain Relief after Stereotactic Radiotherapy of Pancreatic Adenocarcinoma: An Updated Systematic Review”
by Milly Buwenge, Alessandra Arcelli, Francesco Cellini, Francesco Deodato, Gabriella Macchia, Savino Cilla, Erika Galietta, Lidia Strigari, Claudio Malizia, Silvia Cammelli et al.
Curr. Oncol. 2022, 29(4), 2616-2629; https://doi.org/10.3390/curroncol29040214
“Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies”
by Miguel A. Ortega, Leonel Pekarek, Oscar Fraile-Martinez, Cielo Garcia-Montero, Miguel A. Saez, Angel Asúnsolo, Miguel A. Alvarez-Mon, Jorge Monserrat, Lidia Ruiz-Llorente, Natalio García-Honduvilla et al.
Curr. Oncol. 2022, 29(4), 2442-2453; https://doi.org/10.3390/curroncol29040198
“Prognostic Impact of Resection Margin Status on Distal Pancreatectomy for Ductal Adenocarcinoma”
by Maia Blomhoff Holm and Caroline Sophie Verbeke
Curr. Oncol. 2022, 29(9), 6551-6563; https://doi.org/10.3390/curroncol29090515
“Preoperative C-Reactive Protein-to-Albumin Ratio Predicts Postoperative Pancreatic Fistula following Pancreatoduodenectomy: A Single-Center, Retrospective Study”
by Naotake Funamizu, Takeshi Utsunomiya, Masahiko Honjo, Chihiro Ito, Mikiya Shine, Mio Uraoka, Tomoyuki Nagaoka, Kei Tamura, Katsunori Sakamoto, Kohei Ogawa et al.
Curr. Oncol. 2022, 29(12), 9867-9874; https://doi.org/10.3390/curroncol29120775
“Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights”
by Rita Balsano, Valentina Zanuso, Angelo Pirozzi, Lorenza Rimassa and Silvia Bozzarelli
Curr. Oncol. 2023, 30(4), 3871-3885; https://doi.org/10.3390/curroncol30040293
“An Overview of Pancreatic Neuroendocrine Tumors and an Update on Endoscopic Techniques for Their Management”
by Osama O. Elkelany, Fred G. Karaisz, Benjamin Davies and Somashekar G. Krishna
Curr. Oncol. 2023, 30(8), 7566-7580; https://doi.org/10.3390/curroncol30080549
“Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma—A Critical Review of Randomised Trials”
by Mathilde Weisz Ejlsmark, Tine Schytte, Uffe Bernchou, Rana Bahij, Britta Weber, Michael Bau Mortensen and Per Pfeiffer
Curr. Oncol. 2023, 30(7), 6820-6837; https://doi.org/10.3390/curroncol30070499
“Narrative Review of Immunotherapy in Gastroentero-Pancreatic Neuroendocrine Neoplasms”
by Jasmeet Kaur and Namrata Vijayvergia
Curr. Oncol. 2023, 30(9), 8653-8664; https://doi.org/10.3390/curroncol30090627
You are welcome to submit relevant papers to the journal Current Oncology. For any questions, please feel free to contact us.
Current Oncology Editorial Office
